These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18683506)

  • 61. [Regulation of the transcription of the tyrosine aminotransferase gene by glucocorticoids in Morris hepatoma 7777 and 8994 cells].
    Adler VV; Krasil'nikov MA; Polotskaia AV
    Mol Biol (Mosk); 1988; 22(2):423-9. PubMed ID: 2899290
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of the nuclear proteins binding the CACCC element of a glucocorticoid-responsive enhancer in the tyrosine aminotransferase gene.
    DeVack C; Lupp B; Nichols M; Kowenz-Leutz E; Schmid W; Schütz G
    Eur J Biochem; 1993 Feb; 211(3):459-65. PubMed ID: 8094667
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements.
    Nitsch D; Boshart M; Schütz G
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5479-83. PubMed ID: 8100067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glucose-6-phosphate dehydrogenase and gama-glutamyltranspeptidase activities in the liver during chemically induced hepatocarcinogenesis in rats and mice.
    Kojima S; Hama Y; Kubodera A
    Toxicol Appl Pharmacol; 1981 Aug; 60(1):26-32. PubMed ID: 6116299
    [No Abstract]   [Full Text] [Related]  

  • 65. Alterations in the hepatic glucocorticoid response to mirex treatment.
    Brown LD; Wilson DE; Yarbrough JD
    Toxicol Appl Pharmacol; 1988 Feb; 92(2):203-13. PubMed ID: 2893471
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of hepatic tyrosine aminotransferase in the frog Rana temporaria.
    Ohisalo JJ; Pispa JP
    Biochim Biophys Acta; 1975 Jul; 397(1):94-100. PubMed ID: 238638
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glucocorticoid receptor IB: mediator of anti-inflammatory and teratogenic functions of both glucocorticoids and phenytoin.
    Katsumata M; Gupta C; Goldman AS
    Arch Biochem Biophys; 1985 Dec; 243(2):385-95. PubMed ID: 2867743
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The cyclic adenosine 3',5'-monophosphate- and the glucocorticoid-dependent enhancers are targets for insulin repression of tyrosine aminotransferase gene transcription.
    Ganss R; Weih F; Schütz G
    Mol Endocrinol; 1994 Jul; 8(7):895-903. PubMed ID: 7984151
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Suppression by delta 9-tetrahydrocannabinol of induction of hepatic tyrosine aminotransferase and tryptophan oxygenase.
    Friedman MA; Wrenn JM
    Toxicol Appl Pharmacol; 1977 Aug; 41(2):345-52. PubMed ID: 19858
    [No Abstract]   [Full Text] [Related]  

  • 70. Glucocorticoid hormones increase the activity of plasma membrane alkaline phosphodiesterase I in rat hepatoma cells.
    Rousseau GG; Amar-Costesec A; Verhaegen M; Granner DK
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1005-9. PubMed ID: 6102383
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amplifying effect for glucocorticoid actions by a new polypeptide from enteric flora.
    Katunuma N; Tanaka T; Saheki T; Kusumi T
    Adv Enzyme Regul; 1974; 12():167-83. PubMed ID: 4156821
    [No Abstract]   [Full Text] [Related]  

  • 72. Regulation of glucocorticoid receptors during adaptive liver growth.
    Thottassery JV; Yarbrough JD
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G603-9. PubMed ID: 1673321
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduced glucagon induction of tyrosine aminotransferase in perfused livers after ethanol treatment.
    Morland J
    Biochem Pharmacol; 1974 Dec; 23(23):3239-46. PubMed ID: 4155305
    [No Abstract]   [Full Text] [Related]  

  • 74. [Glucocorticoid receptors and metabolic disorders of the liver and heart following immobilization].
    Bobkov AI; Kisliakova VP
    Fiziol Zh SSSR Im I M Sechenova; 1981 Aug; 67(8):1258-64. PubMed ID: 6116630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The molecular mechanism of the action of the pharmacological doses of glucocorticoids. Studies on the low-affinity glucocorticoid receptor.
    Le YY; Xu RB
    Receptor; 1995; 5(1):63-9. PubMed ID: 7613485
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activation of tyrosine aminotransferase expression in fetal liver by 5-azacytidine.
    Rothrock R; Perry ST; Isham KR; Lee KL; Kenney FT
    Biochem Biophys Res Commun; 1983 Jun; 113(2):645-9. PubMed ID: 6191758
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects Mifepristone on Aminotransferase Activities in the Liver in Rats with Streptozotocin-Induced Diabetes Mellitus.
    Pal'chikova NA; Selyatitskaya VG; Kuz'minova OI; Pasechnaya KV
    Bull Exp Biol Med; 2018 Aug; 165(4):474-477. PubMed ID: 30121910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue.
    P'eng FK; Lui WY; Chang TJ; Kao HL; Wu LH; Liu TY; Chi CW
    Cancer; 1988 Nov; 62(10):2134-8. PubMed ID: 2460210
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Use of the tyrosine aminotransferase induction system for the demonstration of the signal effect of glucocorticoid hormones].
    Giesen EM; Beck G
    C R Seances Soc Biol Fil; 1981; 175(1):104-8. PubMed ID: 6112052
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tyrosine aminotransferase in senescent rat liver.
    Weber A; Guguen-Guillouzo C; Szajnert MF; Beck G; Schapira F
    Gerontology; 1980; 26(1):9-15. PubMed ID: 6101318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.